Damora Therapeutics Initiates Phase 1/1b Trial of DMR-001
WALTHAM, Massachusetts, August 5, 2026 Damora Therapeutics, Inc. announced the initiation of the global Phase 1/1b CLARITY-101 clinical trial...
mutCALR
Advertisement
Damora Therapeutics Launches Phase 1 Trial of DMR-001
WALTHAM, Mass., Aug. 5, 2026 Damora Therapeutics, Inc. has announced the initiation of the global Phase 1/1b CLARITY-101 clinical...
Biohaven Unveils Promising BHV-1530 Cancer Data at ESMO
NEW HAVEN, Conn., July 20, 2026 Biohaven Ltd. has announced that new Phase I clinical data for BHV-1530, its...
Halozyme and Incyte Join Forces to Improve Cancer Drug Delivery
SAN DIEGO, July 20, 2026 Halozyme Therapeutics has entered into a global collaboration and license agreement with Incyte to...
SNIS 2026 Unveils AI Breakthrough in Brain Tumor Treatment
SEATTLE, July 20, 2026 The Society of NeuroInterventional Surgery (SNIS) has unveiled a series of groundbreaking scientific presentations for...
Advertisement
